<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT921-13350</title>
	</head>
	<body>
		<main>
			<p>920122 FT  22 JAN 92 / Celltech cuts losses and plans listing Celltech Group, the UK's largest independent biotechnology company, halved its pre-tax losses and is hoping to seek a listing for its shares by 1994. A loss of Pounds 6.58m (Pounds 12.5m) was incurred for the year to September 30, on turnover of Pounds 17m (Pounds 19.9m). The company has completed a restructuring programme and its research is now focused on projects aimed at large markets such as cancer therapy and transplant technology. The biologics division, which provides services to other companies and comprises the company's manufacturing operation, increased its contribution to Pounds 500,000 (Pounds 350,000).</p>
		</main>
</body></html>
            